Century Therapeutics (IPSC) Other Non-Current Assets (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Other Non-Current Assets data on file, last reported at $208000.0 in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $208000.0, down 92.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $208000.0 (down 92.5% YoY), and the FY2025 annual result was $2.4 million, up 346.78% from the prior year.
• Other Non-Current Assets retreated to $208000.0 in Q1 2026 per IPSC's latest filing, from $2.4 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.8 million in Q3 2024 and troughed at $208000.0 in Q1 2026.
• A 5-year average of $1.8 million and a median of $2.0 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets soared 410.81% in 2024, then slumped 92.5% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then sank by 73.32% to $528000.0 in 2024, then jumped by 346.78% to $2.4 million in 2025, then sank by 91.18% to $208000.0 in 2026.
• Business Quant data shows IPSC's Other Non-Current Assets at $208000.0 in Q1 2026, $2.4 million in Q4 2025, and $2.3 million in Q3 2025.